The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
about
Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancerRole of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyRationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?FROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomyUpdates of prostate cancer staging: Prostate-specific membrane antigenSalvage radiotherapy after radical prostatectomy: prediction of biochemical outcomesPredicting disease progression from short biomarker series using expert advice algorithmLong-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial.Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy[-2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first reportCurrent approaches, challenges and future directions for monitoring treatment response in prostate cancer.Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells.Salvage treatment in prostate cancer: a clinical approach.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Progress and controversies: Radiation therapy for prostate cancer.Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer.Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.Current use of PSMA-PET in prostate cancer management.New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography.Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients.Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses.Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.CAPRA-S predicts outcome for adjuvant and salvage external beam radiotherapy after radical prostatectomy.Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study.The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.Salvage radiation therapy 11 years after a radical prostatectomy.Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques.Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy.Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome.Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning?
P2860
Q26747782-223A70B3-F509-4BCB-9F48-F8F3C0068C7DQ26765872-43059634-2C59-4CA2-AF7A-7D7469CEE81FQ26774847-6B33F539-E2ED-4D17-9375-B7B8DF83746FQ26827690-713F5401-83F7-4C99-BACE-1EBB48011ED1Q28079444-7A773092-3F9E-4550-AEFE-57EB47A97624Q28541306-A04FE55C-D918-4989-AB82-09531A1E7D90Q30844746-8B790FF3-1D86-449E-99DE-74B01C165E10Q34325482-2F78B61E-BAFC-48C9-AA79-7E1524D0386CQ35685540-53DF3923-AD99-413D-89E9-6D74DCF5B71BQ35835157-0ABABD23-6FB9-4AD1-89AA-5848754010B7Q35924258-C9F6FFB2-0739-4931-95D1-BCD281429D81Q35969948-D8CB8059-9091-42D9-A8F6-5800656F3FC1Q37435181-BF51A6A6-AE6D-48AE-8716-8547A60208E2Q37437499-C8ED375A-9B0B-4F20-8C04-30343159BDE2Q38101613-0F649AFE-5C93-4BA4-991E-F592BBA04547Q38190115-6FFFA856-45F8-4B9F-87E7-A9DE0CEA3634Q38192714-E37E1DA7-385B-49AC-B154-0412BF8805E9Q38252429-CDE5DFDB-1AE6-4C6B-A176-A7B5BF4EBA19Q38264782-D7948172-FF16-4076-A19D-0318D791F0B5Q38602697-1A4D718A-89F9-45FF-AFF5-2B29C2624F33Q38628225-A37DDE5C-2C1F-4F69-B3F0-66848C18FF51Q38699141-D8B43956-B289-4687-B9EC-2196D9E616F1Q38705877-7F67EC43-7A8D-4F51-B841-8DA054E1378AQ38744524-D26E08A5-DEC1-4D1C-AE88-C935B591E802Q38757513-AECCA7B1-A78A-4520-82A8-49892619E442Q38788456-415ADF8A-0B88-4321-873C-D37FE6FD4825Q38877792-626AC8BF-65D5-4A4E-BF89-21697712421CQ39221920-F75CEE03-25F1-40CA-8E61-D83B7D182137Q40258902-3C11B31D-0152-4C6C-9E49-F98D2471B3F3Q40460561-A5519324-FF43-4BD4-A90D-FDE007814065Q40544518-52FC0EEF-ED63-4773-8829-2353C3FDBCC9Q41435839-14C27B5C-4E37-4645-8585-DD598AD7310FQ41469013-E7CEF711-C417-4F08-89A6-525D4C23887BQ41599603-2D805973-CC1D-4238-89FE-4126970DF65DQ41870659-A41794E3-4C2F-48A0-81F9-3E1DF8D7CDCBQ42139974-570E6A9B-18CA-40C9-9460-197DEFF570A2Q45990993-50045120-3B1D-490B-8CE6-774808D1FB47Q46062252-6731CF70-4753-4F0B-B966-0D3625F28DE6Q46748035-BB671810-3FD5-4A7F-B2CB-023A596BFC31Q47253086-3FF81ABE-C9E9-4144-BF73-C1E8F5746F50
P2860
The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
@en
type
label
The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
@en
prefLabel
The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
@en
P1476
The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
@en
P2093
Christopher R King
P304
P356
10.1016/J.IJROBP.2011.10.069
P407
P577
2012-07-14T00:00:00Z